Portfolio company
Panakeia
United Kingdom
Raised
Undisclosed
Latest stage
Seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
SourceFunding history · 1
Similar companies
Mindpeak
This company develops artificial intelligence software for automated tissue analysis and cancer diagnostics for pathology laboratories and pharmaceutical firms.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Proscia
This company develops a digital pathology platform and artificial intelligence software for laboratories, hospitals and biopharmaceutical organisations.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
Persona-Dx
The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
